Public signalCompany raiseAuto-indexed · Unverified
Capital Rx, Inc. raised $230.8M
Capital Rx, Inc.· NEW YORK, US· Other· Filed Sep 26, 2025
Capital Rx, Inc. reported raising capital. Based in NEW YORK, NEW YORK, US. First sale reported 2025-08-12. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$230.8M
Confidence90%
Raised
$230.8M
Investors
8
Jurisdiction
DELAWARE
On the record
- Location
- NEW YORK, US
- Sector
- Other
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $230.8M
- Target amount
- $232.9M
- Filing date
- Sep 26, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Other
- Number of investors
- 8
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $232.9M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
A. J. Loiacono
Director
New York, US
Daniel Delmastro
Director
New York, US
Holly Maloney
Director
New York, US
Jared Kesselheim
Director
New York, US
Kevin Hill
Director
New York, US
Lenard Marcus
Director
New York, US
Mark Kandrysawtz
Director
New York, US
Mostafa Kamal
Director
New York, US
Robert Mittendorff
Director
NEW YORK, US
Ryan Kelly
Director
New York, US
Sources & provenance
“Operating company sold 230,820,898 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Sep 26, 2025. Details beyond the filing have not been verified.
Tags
USCompanyOtherOver $100MCompany Raise
Are you associated with Capital Rx, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record